Sodium Zirconium Cyclosilicate not checked
FollowEvery change as it happens, and a Monday email
Trials
3 active
15 in total · 4 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “A 28-day period during which SZC is administered orally once daily (QD) to maintain normokalaemia. A dose titration regimen starting with QD administration of the dose of SZC the participants received TID in the CP will be studied in the MP and continued in the LTMP. The maximum dose that can be used is the calculated body weight equivalent to the 15 g adult dose”In the company’s words, NCT03813407 on ClinicalTrials.gov
- Tested for
- Hyperkalemia, Hyperkalaemia
- Main trialPhase 4
- “This is a Phase IV, multicentre, open-label, non-comparative study evaluating Lokelma (sodium zirconium cyclosilicate, SZC) in approximately 100 Indian adults with mild to moderate hyperkalaemia.”In the company’s words, NCT07944378 on ClinicalTrials.gov
- Other names
- Lokelma TM · SZC · Lokelma
Other drugs for Hyperkalemia
Coming up2
- 30 Oct 2027Phase 4 trial completes · ClinicalTrials.gov
- 21 Feb 2030Phase 3 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 18 NovNew trial: none to Phase 4 · ClinicalTrials.gov NCT07944378
Trials15
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Recruiting | 30 Oct 2027 | A Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With Hyperkalaemia | |
| Phase 3Recruiting | 21 Feb 2030 | An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia | |
| Phase 4Terminated | 17 Nov 2021 | Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia | |
| Phase 4Completed | 15 Jul 2024 | Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone | |
| Phase 4Completed | 10 Dec 2024 | Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study | |
| Phase 3Completed | 3 Jan 2022 | Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects | |
| Phase 3Terminated | 14 Sep 2022 | Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease | |
| Phase 3Completed | 15 Sep 2022 | A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia. | |
| Phase 3Terminated | 7 Feb 2024 | A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia | |
| Phase 3Terminated | 7 Mar 2024 | Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes) | |
| Phase 2Terminated | 22 May 2020 | Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure | |
| Phase 1Completed | 16 Sep 2021 | Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects | |
| Phase 3Ended | not given | Sodium zirconium cyclosilicate to allow liberal fruit and vegetable intake for patients with CKD stage 3b and 4 (LIBERAL study) | |
| Phase 3Ended | not given | A Randomized Clinical Trial, Multicentre, Open-label, Parallel-group, to define the best Strategy for the management of hEart failure aNd chronic kidney disease among elderly patients with or at high risk of hyperKalemia in spAin by optimizing the use of RAASi with SZC: SENEKA Study | |
| Phase 3Authorised | not given | Phase III, multicenter, open-label, randomized clinical trial to evaluate efficacy of Sodium Zirconium Cyclosilicate (Lokelma) compared to standard of care to manage hyperkalemia in patients with chronic kidney disease (CKD) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026